Inovio Pharmaceuticals
INO
INO
118 hedge funds and large institutions have $176M invested in Inovio Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 106 → 118 (+12)
0.26% more ownership
Funds ownership: 2.25% → 2.5% (+0.26%)
Holders
118
Holding in Top 10
–
Calls
$2.57M
Puts
$1.52M
Top Buyers
| 1 | +$5.73M | |
| 2 | +$5.65M | |
| 3 | +$1.58M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$1.28M |
| 5 |
Morgan Stanley
New York
|
+$1.14M |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$1.1M | |
| 3 | -$992K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$489K |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
-$476K |